Outset Medical (OM) | Stock Overview & Key Data
Outset Medical Performance Comparison
Stock Range
Today's Range
Low: $13.18
High: $13.99
on August 21, 2025
52 Week Range
Low: $5.85
High: $25.35
on March 18, 2025
on January 6, 2025
All-Time High: $1,004.40 on November 16, 2020
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$237.2M
EPS
-18.75
P/E Ratio (TTM)
-0.36
Forward P/E
-10.11
P/B Ratio
1.57
PEG Ratio
0.00
Div. Yield
N/A
ROE
-87.65%
Beta
2.137
Debt to Equity
63.59
Financial Highlights
Profitability
Gross Margin
37.77%
Operating Margin
-53.68%
Profit Margin
-82.06%
Returns and Earnings
Return on Assets (TTM)
-15.79%
Return on Equity (TTM)
-87.65%
EBITDA
$-70.9M
Net Income (TTM)
$-97.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$33.80
Quarterly Revenue Growth (YoY)
14.70%
Quarterly Earnings Growth (YoY)
14.72%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Outset Medical OM | 237.18M Micro-cap | 6.05% | -21.93% | -26.51% | 4.19% | -22.11% | 28.48% | -95.12% | -98.48% |
| Abbott Laboratories ABT | 229.31B Mega-cap | 2.10% | 6.09% | -0.79% | -2.16% | 16.36% | 17.14% | 29.54% | 19.14% |
| Boston Scientific BSX | 153.73B Large-cap | 1.02% | 1.38% | 0.54% | 0.69% | 17.71% | 32.89% | 159.65% | 156.42% |
| TriSalus Life TLSI | 249.84M Micro-cap | 27.84% | 8.53% | -8.82% | -14.04% | -0.40% | -11.59% | -49.90% | -51.94% |
| Cerus CERS | 237.71M Micro-cap | -5.51% | -13.04% | -4.00% | -27.27% | -23.57% | -48.50% | -72.09% | -80.83% |
| Quanterix QTRX | 233.72M Micro-cap | 6.61% | -6.56% | 0.62% | -35.89% | -55.02% | -64.15% | -48.95% | -86.28% |
Ownership & Short Interest
Insider Ownership
2.68%
Institutional Ownership
103.12%
Shares Short
2M
Short Ratio
7.49
Short % of Shares Outstanding
12.27%
Average 10-Day Volume
359K
Average 90-Day Volume
320K
Outset Medical Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Outset Medical would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is OM's 52-week high and low?
- In the last 52 weeks, Outset Medical reached a high of $25.35 (on January 6, 2025) and a low of $5.85 (on March 18, 2025).
- What is the market cap and P/E ratio for OM?
- Curious about Outset Medical's size and valuation? Its market capitalization stands at 237.18M. When it comes to valuation, the P/E ratio (trailing twelve months) is -0.36, and the forward P/E (looking ahead) is -10.11.
- Does OM pay dividends? If so, what's the yield?
- As for dividends, Outset Medical isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Outset Medical's main competitors or similar companies to consider before investing?
When looking at Outset Medical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT229.31B Healthcare Medical Devices 17.14% 29.54% Boston Scientific
BSX153.73B Healthcare Medical Devices 32.89% 159.65% TriSalus Life
TLSI249.84M Healthcare Medical Devices -11.59% -49.90% Cerus
CERS237.71M Healthcare Medical Devices -48.50% -72.09% Quanterix
QTRX233.72M Healthcare Medical Devices -64.15% -48.95% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Outset Medical Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Outset Medical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -87.65%, the Debt to Equity ratio from the most recent quarter is 63.59, and its Gross Profit Margin stands at 37.77%.
- What is the recent revenue and earnings growth for OM?
- Looking at Outset Medical's growth, its revenue over the trailing twelve months (TTM) was $119M. Compared to the same quarter last year (YoY), quarterly revenue grew by 14.70%, and quarterly earnings saw a YoY growth of 14.72%.
- How much of OM stock is held by insiders and institutions?
- Wondering who owns Outset Medical stock? Company insiders (like executives and directors) hold about 2.68% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 103.12%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.